{"name":"National Center for Tumor Diseases, Heidelberg","slug":"national-center-for-tumor-diseases-heidelberg","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxPQ0FBUkhCRGYwdzNGZ2ZRY2hadVJpempZQXE5QUFzZVZNOF9TV2ZFSmlnY05qajhZMEh3UTBwVklJNGxMMHJKSjhSQnNkcTlRTEZMMnkwV3Nyd3NrVnVjUnNBMmk5ME9sYmRITkJtV2JGRVgxX2VpWEZLOEFRU3JIcA?oc=5","date":"2025-10-23","type":"regulatory","source":"Cure Today","summary":"FDA Fast Tracks HDP-101 For Multiple Myeloma - Cure Today","headline":"FDA Fast Tracks HDP-101 For Multiple Myeloma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFBZQ3pkZXRhYVp0NzU4UmJ4LU5yei1pbXZBanNFMEhUSVlERkluMkozV3ZXcHdfcUhRekh6YUdwel9VNjY4Tm52WVc2c3VnMHZWai1wMjBOSTBldzk4MjhZ?oc=5","date":"2025-10-20","type":"regulatory","source":"nature.com","summary":"Prospective systematic classification of causes of death in the course of multiple myeloma | Blood Cancer Journal - nature.com","headline":"Prospective systematic classification of causes of death in the course of multiple myeloma | Blood Cancer Journal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE9aOGNiaVFUQWU3MTZWSjVmaEdKT2ZoVzdjS3VLZTZlMzF1Z0ZXVUlObzFoRTNySXNzY2JZQkVLbTRPeTBXWEFMLW9kd2YyMk1LWElhQU9Md1JiMlE0d3BF?oc=5","date":"2025-10-10","type":"pipeline","source":"nature.com","summary":"Automated radiomics model for prediction of therapy response and minimal residual disease from baseline MRI in multiple myeloma - nature.com","headline":"Automated radiomics model for prediction of therapy response and minimal residual disease from baseline MRI in multiple ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXEFVX3lxTE92eVU3aWprek9QbG9QcnlIRUJsMFg0TWtYU0twZVNNb0x5bmlJSXgwWHhZUjFWWGg2NE5Gb20wSkZXUmZMRk1hNzc5N0p4MFhIVnpSZHd4RUVRa2NG?oc=5","date":"2025-09-17","type":"pipeline","source":"EurekAlert!","summary":"New targeted radiation therapy shows near-complete response in rare sarcoma patients - EurekAlert!","headline":"New targeted radiation therapy shows near-complete response in rare sarcoma patients - EurekAlert!","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE5qLXo1SUJoRVktVTVESnlvekloaWFnSEZkMXA2UGpjQ05SUlNvRjJ0QjhsSUhaMlBoNGVsSHBwX3JrNENmX3RzaEEwWmVYS284UFV6UHN1aEdsNXdBUTRv?oc=5","date":"2025-07-14","type":"pipeline","source":"nature.com","summary":"DNA demethylation-mediated downregulation of MNX1 in acute myeloid leukemia - nature.com","headline":"DNA demethylation-mediated downregulation of MNX1 in acute myeloid leukemia","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE84SjdwT1E0U1dOSFZRNlpleXlsZ1Y1YUYtb1dxWGU2ZWNxNVlTVFRILWw5ZGJYaVdWUEt6ZVJnZmM1NTBwS1pRaF9URDJ4WHViNUx4aDNxVk44YnFTOHJmMUdjR3cta3hkT0pvNHc0QnF1YUFSdERwdDdhTmE?oc=5","date":"2025-07-01","type":"pipeline","source":"Goethe-Universität Frankfurt","summary":"Sina Oppermann, Pharmacist - Goethe-Universität Frankfurt","headline":"Sina Oppermann, Pharmacist - Goethe-Universität Frankfurt","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxQTEZGczVDQ3EzSnV4dHh0QmhDWmpEV0dlQm1fSXVzZ2l1UmFmMnhGLXphWnVJa1diWnAxcUhIcUZXOEhzS083aHBDWmtRalQ1REg4OGxVbE5idVgwdTVhaDhaejJzMUNYMkw5V0x4eVlNdHV0YmNjczNmZXBEVGdHTGNIR0wxOVRnRUt1WVBGMWVTODJBTVl6Qi16bkFMYm9rVVQ1cTNtR0E2MTJtSWFXek9Ub01PTWZ5OTBR?oc=5","date":"2025-01-10","type":"pipeline","source":"biotechniques.com","summary":"CTC-derived organoids establish new tool for investigation of metastasis - biotechniques.com","headline":"CTC-derived organoids establish new tool for investigation of metastasis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE8tS1hGeTF0ZG1WZjRYamI2Z3c0QTRXS3dkZkdRcE5pWVBrS3Z0Uy1YS0lSQlIzWHltU3VrSFJjaS1yemxYRkZxVnVWeWtxNUtyTXBtWkZYRGdjZFBJdG1z?oc=5","date":"2025-01-03","type":"pipeline","source":"nature.com","summary":"Circulating tumor cell plasticity determines breast cancer therapy resistance via neuregulin 1–HER3 signaling - nature.com","headline":"Circulating tumor cell plasticity determines breast cancer therapy resistance via neuregulin 1–HER3 signaling","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE5CX3h6Q3B3V1Rnd3VJWWJSdWcwbGVGX2gzeHo4Q1V1MjQ5S3RUYkYzcTNYUWtvNFZUbjVfQXV2WVBBekk5QkE1dUQzNzY3dG05U01kTUNqcTVINjcyMXBN?oc=5","date":"2024-06-03","type":"regulatory","source":"nature.com","summary":"CD8+ CD28− regulatory T cells after induction therapy predict progression-free survival in myeloma patients: results from the GMMG-HD6 multicenter phase III study | Leukemia - nature.com","headline":"CD8+ CD28− regulatory T cells after induction therapy predict progression-free survival in myeloma patients: results fro","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFAzeTczX1hveFVGNl9wUEtsY2Y4WTQ2N08xb191bV9rNjZOZDJpRzNlbDZ1VEFGQURqc1REN2VqczM3LUpTanQ4Yk0zcG5YOTJxUGhUaW5UTk9PUGlmSGgw?oc=5","date":"2022-02-24","type":"pipeline","source":"nature.com","summary":"The Molecular Tumor Board Portal supports clinical decisions and automated reporting for precision oncology - nature.com","headline":"The Molecular Tumor Board Portal supports clinical decisions and automated reporting for precision oncology","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxPZnctNHlneFZzY0RwSWV1TUhUd3pLUEIzYVZOb0tRNTduWTZfWkpXdUZUT3JacGozQVJFU0NHYUFSYlFLV0dDZHp2Z2xaZlJ6Y1VReHZPMHc0dklpUEd3d0ZJSHd0QkNLN18yeDN1M2NmS3JnSklscjBmSnE2cHN6VmV6V2Vfd0ttWHd4Tw?oc=5","date":"2021-07-13","type":"pipeline","source":"Frontiers","summary":"Effectiveness of Carbon Ion Radiation in Locally Advanced Pancreatic Cancer - Frontiers","headline":"Effectiveness of Carbon Ion Radiation in Locally Advanced Pancreatic Cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiW0FVX3lxTE42Yi02STZMRF94TGU1clR2X29nN0ZlelB1Wm5KVGF5R1ZOb2NyRmVBeFhpaXl3REdNMmplaTI1VDRwNVNTMFlCRTd2Y0hHTVdVVUpOQ0xhNThWTmM?oc=5","date":"2018-10-15","type":"pipeline","source":"EurekAlert!","summary":"Financial impacts of cancer found to intensify disease burden among German patients - EurekAlert!","headline":"Financial impacts of cancer found to intensify disease burden among German patients - EurekAlert!","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}